Tech Company Financing Transactions
Awak Technologies Funding Round
On 9/13/2023, Awak Technologies raised $20 million in Series B funding from Vickers Venture Partners, Advanced MedTech and Eckuity Capital.
Transaction Overview
Company Name
Announced On
9/13/2023
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to complete the ongoing human pre-pivotal clinical trial, further enhance the products and portfolio, and get closer to a US-based pivotal trial before launching in the US market.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3 Tuas Ln
Singapore, 638612
SG
Singapore, 638612
SG
Phone
Website
Email Address
Overview
AWAK is a patient-centric medical technology company with a mission to enhance the lives of dialysis patients and their caregivers by providing solutions to deliver better outcomes along with improving their quality of life. AWAK sorbent technology is a platform technology which is revolutionising both peritoneal dialysis and hemodialysis. Our technology in enabling development of ultra-portable PD and HD machines, thus giving freedom to patients and enhancing their quality of life.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Suresha Venkataraya
Chief Marketing Officer
Mandar Gori
Browse more venture capital transactions:
Prev: 9/13/2023: Science On Call venture capital transaction
Next: 9/13/2023: Cleverly venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs